Floatz logo

cyc140

Solid Tumor, Adult Lymphoma

Cyclacel Pharmaceuticals, Inc.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Solid Tumor, Adult Lymphoma cohort.

Asset / SponsorPhaseRating
Decitabine
Children's Hospital Medical Center, Cincinnati
Early Phase 1CC
Pembrolizumab
Children's Hospital Medical Center, Cincinnati
Early Phase 1CC
hlx51
Shanghai Henlius Biotech
Phase 1NR

Same molecule, other indications

cyc140 is also rated in:

adult acute lymphoblastic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
chronic myeloid leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →